We are live on ! Find out more
PZRX

PhaseRx, Inc.
PZRX

Delisted

PZRX was delisted on the 2nd of February, 2018.

8 hedge funds and large institutions have $1.56M invested in PhaseRx, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.33% less ownership

Funds ownership: 9.91%8.58% (-1.3%)

11% less funds holding

Funds holding: 98 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

48% less capital invested

Capital invested by funds: $2.98M → $1.56M (-$1.42M)

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PZRX Hedge Fund Activity: Q4 2016 in Review

8 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q4 2016, worth a combined $1.56M — down 48% from $2.98M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PZRX and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $213K. The largest seller was Fidelity Investments, cutting an estimated $482K.

  • 8 institutional investors held PhaseRx, Inc. (PZRX) as of Q4 2016, down from 9 in Q3 2016.
  • Funds reported $1.56M of PhaseRx, Inc. stock for Q4 2016, down 48% quarter-over-quarter.
  • 3 funds opened new PhaseRx, Inc. positions in Q4 2016 and 4 closed out, a net change of -1 holder.
  • The largest PhaseRx, Inc. buyer in Q4 2016 was Vanguard Group, an estimated $213K added.
  • The largest PhaseRx, Inc. seller in Q4 2016 was Fidelity Investments, an estimated $482K sold.

Based on aggregated 13F filings for Q4 2016.